Biotech Values

[DewDiligence]

NVS/MNTA defense arguments in Copaxone patent case:

Click here for Court document (8/24/11; 6 pages)


A. Non-infringement

B. Invalidity

• Obviousness
• Lack of Enablement
• Indefiniteness*
• Lack of Best Mode

C. Unenforceability (inequitable conduct)


*Summary judgment denied by Court (#msg-54139320, #msg-66626914).

Thanks to ‘mouton29’ for making this document available.